The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization

BACKGROUND: Our objective was to investigate the existence of an optimal period for oocyte retrieval in regards to the clinical pregnancy occurrence after the administration of recombinant human chorionic gonadotropin (rhCG) (Ovitrelle®). METHODS: We studied the digital records of 3362 middle easter...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Rahwanji, Mhd Jawad, Abouras, Homam, Shammout, Mhd Said, Altalla, Ray, Al Sakaan, Reem, Alhalabi, Nawras, Alhalabi, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902772/
https://www.ncbi.nlm.nih.gov/pubmed/35255857
http://dx.doi.org/10.1186/s12884-022-04412-9
_version_ 1784664661281472512
author Al Rahwanji, Mhd Jawad
Abouras, Homam
Shammout, Mhd Said
Altalla, Ray
Al Sakaan, Reem
Alhalabi, Nawras
Alhalabi, Marwan
author_facet Al Rahwanji, Mhd Jawad
Abouras, Homam
Shammout, Mhd Said
Altalla, Ray
Al Sakaan, Reem
Alhalabi, Nawras
Alhalabi, Marwan
author_sort Al Rahwanji, Mhd Jawad
collection PubMed
description BACKGROUND: Our objective was to investigate the existence of an optimal period for oocyte retrieval in regards to the clinical pregnancy occurrence after the administration of recombinant human chorionic gonadotropin (rhCG) (Ovitrelle®). METHODS: We studied the digital records of 3362 middle eastern couples who underwent in vitro fertilization (IVF) treatment between 2019 and 2021. RESULTS: Through statistical testing, we found that there is a significant positive correlation between the oocyte retrieval period and the clinical pregnancy occurrence up to the 37th hour, where retrieval at the 37th hour was found to provide the most optimal outcome, especially in the case of gonadotropin-releasing hormone agonist (GnRHa) long protocol. CONCLUSIONS: This cohort study recommends retrieval at hour 37 after ovulation triggering under the described conditions.
format Online
Article
Text
id pubmed-8902772
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89027722022-03-18 The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization Al Rahwanji, Mhd Jawad Abouras, Homam Shammout, Mhd Said Altalla, Ray Al Sakaan, Reem Alhalabi, Nawras Alhalabi, Marwan BMC Pregnancy Childbirth Research Article BACKGROUND: Our objective was to investigate the existence of an optimal period for oocyte retrieval in regards to the clinical pregnancy occurrence after the administration of recombinant human chorionic gonadotropin (rhCG) (Ovitrelle®). METHODS: We studied the digital records of 3362 middle eastern couples who underwent in vitro fertilization (IVF) treatment between 2019 and 2021. RESULTS: Through statistical testing, we found that there is a significant positive correlation between the oocyte retrieval period and the clinical pregnancy occurrence up to the 37th hour, where retrieval at the 37th hour was found to provide the most optimal outcome, especially in the case of gonadotropin-releasing hormone agonist (GnRHa) long protocol. CONCLUSIONS: This cohort study recommends retrieval at hour 37 after ovulation triggering under the described conditions. BioMed Central 2022-03-07 /pmc/articles/PMC8902772/ /pubmed/35255857 http://dx.doi.org/10.1186/s12884-022-04412-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Al Rahwanji, Mhd Jawad
Abouras, Homam
Shammout, Mhd Said
Altalla, Ray
Al Sakaan, Reem
Alhalabi, Nawras
Alhalabi, Marwan
The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
title The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
title_full The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
title_fullStr The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
title_full_unstemmed The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
title_short The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
title_sort optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902772/
https://www.ncbi.nlm.nih.gov/pubmed/35255857
http://dx.doi.org/10.1186/s12884-022-04412-9
work_keys_str_mv AT alrahwanjimhdjawad theoptimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT abourashomam theoptimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT shammoutmhdsaid theoptimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT altallaray theoptimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT alsakaanreem theoptimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT alhalabinawras theoptimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT alhalabimarwan theoptimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT alrahwanjimhdjawad optimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT abourashomam optimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT shammoutmhdsaid optimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT altallaray optimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT alsakaanreem optimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT alhalabinawras optimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization
AT alhalabimarwan optimalperiodforoocyteretrievalaftertheadministrationofrecombinanthumanchorionicgonadotropinininvitrofertilization

Ejemplares similares